BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2092 related articles for article (PubMed ID: 16766368)

  • 21. T helper cell subsets in the pathogenesis of systemic lupus erythematosus.
    Reininger L; Santiago ML; Takahashi S; Fossati L; Izui S
    Ann Med Interne (Paris); 1996; 147(7):467-71. PubMed ID: 9092356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasculitis in the Palmerston North mouse model of lupus: phenotype and cytokine production profile of infiltrating cells.
    Luzina IG; Knitzer RH; Atamas SP; Gause WC; Papadimitriou JC; Sztein MB; Storrer CE; Handwerger BS
    Arthritis Rheum; 1999 Mar; 42(3):561-8. PubMed ID: 10088780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
    Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
    Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4+ T cell lines with selective patterns of autoreactivity as well as CD4- CD8- T helper cell lines augment the production of idiotypes shared by pathogenic anti-DNA autoantibodies in the NZB x SWR model of lupus nephritis.
    Sainis K; Datta SK
    J Immunol; 1988 Apr; 140(7):2215-24. PubMed ID: 2965184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum cytokine levels and type 1 and type 2 intracellular T cell cytokine profiles in mixed connective tissue disease.
    Bodolay E; Aleksza M; Antal-Szalmás P; Végh J; Szodoray P; Soltész P; Szegedi A; Szekanecz Z
    J Rheumatol; 2002 Oct; 29(10):2136-42. PubMed ID: 12375323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A regulatory role of prolactin, growth hormone, and corticosteroids for human T-cell production of cytokines.
    Dimitrov S; Lange T; Fehm HL; Born J
    Brain Behav Immun; 2004 Jul; 18(4):368-74. PubMed ID: 15157954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidative stress in systemic lupus erythematosus: relationship to Th1 cytokine and disease activity.
    Shah D; Kiran R; Wanchu A; Bhatnagar A
    Immunol Lett; 2010 Mar; 129(1):7-12. PubMed ID: 20105444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B cell apoptosis accelerates the onset of murine lupus.
    Trébéden-Nègre H; Weill B; Fournier C; Batteux F
    Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus.
    Mellor-Pita S; Citores MJ; Castejon R; Yebra-Bango M; Tutor-Ureta P; Rosado S; Andreu JL; Vargas JA
    Cytometry B Clin Cytom; 2009 Jul; 76(4):261-70. PubMed ID: 19199277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
    Hughes GC; Martin D; Zhang K; Hudkins KL; Alpers CE; Clark EA; Elkon KB
    Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages.
    Kang BY; Song YJ; Kim KM; Choe YK; Hwang SY; Kim TS
    Br J Pharmacol; 1999 Sep; 128(2):380-4. PubMed ID: 10510448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of systemic lupus erythematosus syndrome in BALB/c mice by immunization with active chromatin.
    Li H; Zhang YY; Sun YN; Huang XY; Jia YF; Li D
    Acta Pharmacol Sin; 2004 Jun; 25(6):807-11. PubMed ID: 15169636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice.
    Chen M; Aosai F; Norose K; Mun HS; Ishikura H; Hirose S; Piao LX; Fang H; Yano A
    Int Immunol; 2004 Jul; 16(7):937-46. PubMed ID: 15148287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus.
    Shiroiwa W; Tsukamoto K; Ohtsuji M; Lin Q; Ida A; Kodera S; Ohtsuji N; Nakamura K; Tsurui H; Kinoshita K; Nishimura H; Shirai T; Hirose S
    Int Immunol; 2007 Feb; 19(2):175-83. PubMed ID: 17189592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of pro-inflammatory cytokines by TCR alpha beta+ and TCR gamma delta+ T cells in an experimental model of colitis.
    Simpson SJ; Holländer GA; Mizoguchi E; Allen D; Bhan AK; Wang B; Terhorst C
    Eur J Immunol; 1997 Jan; 27(1):17-25. PubMed ID: 9021993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-12 producing monocytes and IFN-gamma and TNF-alpha producing T-lymphocytes are increased in placentas infected by Plasmodium falciparum.
    Diouf I; Fievet N; Doucouré S; Ngom M; Andrieu M; Mathieu JF; Gaye A; Thiaw OT; Deloron P
    J Reprod Immunol; 2007 Jun; 74(1-2):152-62. PubMed ID: 17194481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients.
    Spolarics Z; Siddiqi M; Siegel JH; Garcia ZC; Stein DS; Denny T; Deitch EA
    Crit Care Med; 2003 Jun; 31(6):1722-9. PubMed ID: 12794411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterisation of cellular and humoral autoimmune responses to histone H1 and core histones in human systemic lupus erythaematosus.
    Stummvoll GH; Fritsch RD; Meyer B; Hoefler E; Aringer M; Smolen JS; Steiner G
    Ann Rheum Dis; 2009 Jan; 68(1):110-6. PubMed ID: 18375534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 105.